// App-Quantinova.ai

4592 : MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression

Researchers

Presenter

  • Sheema Khan

Principal Investigators

  • Mara C. Ebeling

  • Mohammad Sikander

  • Murali M. Yallapu

  • Tomoko Ise

  • Satoshi Nagata

  • Stephen W. Behrman

  • Nadeem Zafar

  • Jim Y. Wan

  • Hemendra M. Ghimire

  • Peeyush Sahay

  • Prabhakar Pradhan

  • Meena Jaggi

  • Subhash C. Chauhan

Medical Centers

  • The University of Tennessee Health Science Center, Memphis, TN

  • Sanford Health, Sioux Falls, SD

  • University of Memphis, Memphis, TN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Pancreatic cancer

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Hepatocyte growth factor receptor

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved